D. von Mallek

Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?

F. Juengling, H. Brockmann, M. Wissmeyer, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Does radiotherapy affect the outcome of the comet assay?

C. Streffer, W. Müller, D. von Mallek, 2002, The British journal of radiology.

Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome

H. Palmedo, I. Brink, S. Ezziddin, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Prostate-specific membrane antigen radioligand therapy of prostate cancer.

F. Mottaghy, A. Heinzel, M. Beheshti, 2019, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....

Palliation and Survival After Repeated 188Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis

J. Bucerius, H. Biersack, H. Palmedo, 2011, The Journal of Nuclear Medicine.

[Technical limits of PET/CT with 18FDG in prostate cancer].

H. Biersack, H. Palmedo, U. Jaeger, 2006, Aktuelle Urologie.

Comparison of [99mTc]Tc-tilmanocept with [99mTc]Tc-sulphur colloids and [99mTc]Tc-albumin colloids for sentinel lymph node detection in patients with cutaneous malignancies of the head

F. Hölzle, F. Mottaghy, H. Kaiser, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

Tc-99m Labelled Anti CD 66 Antigranulocyte Antibody Imaging for Assessment of Bone Marrow Reserve

H. Biersack, H. Palmedo, S. Ezziddin, 2005 .

[PET-CT studies of metastasizing cancer of the colon and rectum. Variability of tumor aggressiveness as a micro-evolutionary process of cancer stem cells with predetermined prognosis].

J. Ruhlmann, H. Biersack, D. von Mallek, 2009, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

99mTc‑labeled single-domain antibody for SPECT/CT assessment of HER2 expression in diverse cancer types

F. Mottaghy, E. Stickeler, H. Biersack, 2022, European Journal of Nuclear Medicine and Molecular Imaging.

68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

F. Mottaghy, A. Heinzel, M. Essler, 2019, European Journal of Nuclear Medicine and Molecular Imaging.

Dosing to rash?--The role of erlotinib metabolic ratio from patient serum in the search of predictive biomarkers for EGFR inhibitor-mediated skin rash.

S. Rüdiger, C. Schumann, V. Heinemann, 2016, European journal of cancer.

Effectiveness of syringe shieldings using radionuclides in radiation synovectomy

H. Biersack, H. Palmedo, R. Rödel, 2003, Nuklearmedizin.

[PET-CT studies of the support system and continence function of pelvic organs. The pivotal importance of Denonvilliers' fascia for surgical procedures].

H. Biersack, D. von Mallek, F. Stelzner, 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Breast cancer imaging with PET and SPECT agents: an in vivo comparison.

H. Biersack, H. Palmedo, M. Reinhardt, 2002, Nuclear medicine and biology.

Dose selection for radioiodine therapy of borderline hyperthyroid patients with multifocal and disseminated autonomy on the basis of 99mTc-pertechnetate thyroid uptake

H. Palmedo, T. Krause, M. Reinhardt, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[Incidents of malfunction of mechanical heart valves as reported to the German Medical Devices Vigilance System].

F. Mellert, D. von Mallek, B. Heinz, 2008, Deutsche medizinische Wochenschrift.

[Lymph vascularity and lymph node metastases on PET and PET-CT: immunohistological and clinical observations].

J. Ruhlmann, R. Büttner, H. Steinau, 2005, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.